Intuitive Surgical (NASDAQ:ISRG) Stock: Insider Craig Barratt Sells ...
π Director Craig Barratt sold 1,150 shares for $529,000 on November 4th under a pre-arranged Rule 10b5-1 trading plan.
π° The company reported Q3 earnings of $3.00 per share, beating the consensus estimate of $2.65 by $0.35.
π Revenue for the quarter reached $3.05 billion, exceeding analyst expectations of $2.91 billion.
π Quarterly revenue grew 21.7% year-over-year, demonstrating strong top-line growth momentum.
πΉ The stock achieved a net margin of 25.54% and a return on equity of 18.17% during the quarter.
π¦ Institutional investors own 83.64% of the company's outstanding shares, indicating high confidence.
π Hedge funds including QRG Capital Management increased their positions by 34.0% in the second quarter.
π Wall Street Zen upgraded the stock from a 'Hold' to a 'Buy' rating on October 31st.
π― Analysts maintain a consensus target price of $493.54, suggesting potential upside from current levels.
π¬ The company continues to expand its portfolio with the Ion endoluminal system for lung biopsies.
- Intuitive Surgical reported Q3 earnings of $3.00 per share, significantly beating analyst consensus estimates of $2.65.
- The company generated revenue of $3.05 billion, surpassing the expected $2.91 billion forecast.
- Revenue grew 21.7% year-over-year, highlighting robust demand for its robotic surgical systems.
- Wall Street Zen upgraded the stock from a 'Hold' to a 'Buy' rating in late October.
- QRG Capital Management increased its stake by 34.0% in the second quarter, adding over 24,000 shares.
- NewEdge Advisors boosted its position by 19.1%, now holding a stake worth over $20 million.
- HSBC lowered its rating from 'Buy' to 'Hold' and set a target price of $391.00, which is below the current trading price.
- Director Craig Barratt sold 50% of his direct holdings, though the sale was executed under a pre-arranged trading plan.